The progress of active surveillance of prostate cancer
10.3760/cma.j.cn112330-20240110-00019
- VernacularTitle:前列腺癌主动监测的研究进展
- Author:
Xinyang CAI
1
;
Yu FAN
;
Yonghong LI
Author Information
1. 中山大学肿瘤防治中心泌尿外科 华南肿瘤学国家重点实验室 肿瘤医学协同创新中心，广州 510060
- Keywords:
Prostatic neoplasms;
Carcinoma;
Active surveillance;
Inclusion criteria;
Follow-up strategies
- From:
Chinese Journal of Urology
2024;45(6):477-480
- CountryChina
- Language:Chinese
-
Abstract:
Active surveillance means patients are monitored closely without active treatment immediately. Many studies have shown that active surveillance, as a relatively safe method for prostate cancer patients, can reduce overtreatment, and is one of the main methods for very low risk, low risk and a small proportion of intermediate risk men with a life expectancy more than 10 years. The follow-up process of active surveillance includes regularly repeat needle biopsy, PSA test, digital rectal examination, multiparametric magnetic resonance imaging (mpMRI), etc. However, the monitoring standard and frequency are still not unified. There is still a lack of active surveillance data in China, and further research is needed.
